Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2017
J.J. Lee is an author specializing in pharmacology, ntrk fusion genes, and cancer immunotherapy.
Publications per year
2017–2017
Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
David S. Hong, Afshin Dowlati, Howard A. Burris et al. · European Journal of Cancer · 2017 · 10 citations
Medicine, Oncology, Pharmacology +16
1–1 of 1